Related Experiment Video

Updated: May 25, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine

Simona Di Mario, Vittorio Basevi, Silvana Borsari

    The Lancet. Oncology
    |February 4, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
    13:36

    Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

    Published on: May 6, 2015

    Related Experiment Videos

    Last Updated: May 25, 2026

    Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
    13:41

    Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

    Published on: March 8, 2012

    Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
    13:36

    Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

    Published on: May 6, 2015

    Related Concept Videos

    Vaccinations01:51

    Vaccinations

    Overview
    Cancer Vaccines01:30

    Cancer Vaccines

    Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
    Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
    Vaccines01:21

    Vaccines

    Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

    Articles linked to this work by shared authors, journal, and citation graph.

    Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.

    The Lancet. Oncology·2026

    Comparison of efficacy and toxicity of 2 dactinomycin (ACTD) regimens in the second-line treatment of low-risk gestational trophoblastic neoplasia: a retrospective study.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

    Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02).

    Breast (Edinburgh, Scotland)·2026

    Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial.

    Nature medicine·2026

    Screening of Cytomegalovirus Infection in Pregnant Women. Recommendation by the Italian National Institute of Health and Ministry of Health, December 2023.

    Prenatal diagnosis·2026

    Neoadjuvant immunotherapy in mismatch-repair-proficient colon cancers.

    Nature·2025

    Reporting health-related quality of life in randomised clinical trials evaluating adjuvant systemic therapy: recommendations of Common-Sense Oncology and the European Organisation for Research and Treatment of Cancer.

    The Lancet. Oncology·2026

    Cancer and the microbiome: from association to intervention.

    The Lancet. Oncology·2026

    Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer (CHN HYPOPMRT): 10-year outcomes from a randomised, non-inferiority, open-label, phase 3 trial.

    The Lancet. Oncology·2026

    Global burden of cancer attributable to infections in 2024: a worldwide incidence analysis.

    The Lancet. Oncology·2026

    A reproducible entropy-weighted Gower-CLARA-TOPSIS procedure for mixed-type MSME segmentation and prioritization.

    MethodsX·2026

    Institute-created electronic flashcards, associated development effort, and exam performance in pharmacology education in human medicine.

    Naunyn-Schmiedeberg's archives of pharmacology·2026

    A spiking continuous attractor network for event-driven neuromorphic robot guidance.

    Frontiers in neuroscience·2026

    Sparse Linear Algebra Accelerates Genotype Representation Graph Computation at Biobank Scale.

    bioRxiv : the preprint server for biology·2026

    pileup-hi: an ultra-high-throughput, customizable alignment pileup program for large datasets.

    Bioinformatics (Oxford, England)·2026

    Retrospective Grid Cells in the Medial Entorhinal Cortex Encode Past Paths During Spatial Navigation.

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us